Virtu Financial’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60K Buy
+24,784
New +$60.6K ﹤0.01% 1196
2025
Q2
Sell
-10,402
Closed -$45K 1891
2025
Q1
$45K Sell
10,402
-1,571
-13% -$6.34K ﹤0.01% 1023
2024
Q4
$38K Buy
+11,973
New +$40.2K ﹤0.01% 1199
2024
Q2
Sell
-19,536
Closed -$55K 1735
2024
Q1
$55K Buy
19,536
+3,227
+20% +$11K ﹤0.01% 1009
2023
Q4
$67K Buy
+16,309
New +$45.7K 0.01% 1124

Other funds holding ORGO

Virtu Financial's ORGO Position: Q2 2026 in Review

Virtu Financial opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 24,784 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #1196 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ORGO as recently as Q1 2025.

Virtu Financial first reported a position in ORGO in Q4 2023 and has held it in 5 quarters since. The position peaked at $67K in Q4 2023. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Virtu Financial held 24,784 shares of Organogenesis Holdings worth $60K as of Q2 2026.
  • Organogenesis Holdings was a new Virtu Financial position in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1196 holding.
  • Virtu Financial first reported a position in Organogenesis Holdings in Q4 2023 and has held it in 5 quarters since.
  • Virtu Financial's Organogenesis Holdings position peaked at $67K in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.